Marinus Pharmaceuticals, Inc(NASDAQ:MRNS) 
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including i...
Website: http://www.marinuspharma.com
Founded: 2003
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-13
P
O 1.17
H 1.24
L 1.16
C 1.18
V 344,466
10EMA 1.18
20EMA 1.18
60EMA 1.18
120EMA 1.18
250EMA 1.18